AAPG
Ascentage Sp ADS (AAPG)
NASDAQ
$17.05-$0.08 (-0.47%)
Price as of Jun 23, 2026 2:53 PM EDT
  • $1.6B
    Market Cap
  • -53.89%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
Income Statement
Total Operating Revenue
499.3M
-26.41%
678.4M
N/A
Cost of Revenue
46.7M
+72.62%
27.0M
N/A
Gross Profit
525.2M
-44.81%
951.6M
N/A
Sales and Marketing Expense
353.6M
+80.43%
196.0M
N/A
Research and Development Expense
-1.1B
+20.08%
-947.2M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
Total Operating Expenses
N/A
N/A
N/A
N/A
Operating Profit
N/A
N/A
N/A
N/A
Interest Income
N/A
N/A
N/A
N/A
Interest Expense
-49.5M
-16.43%
-59.3M
N/A
Interest Income and Expense and Net
-49.5M
-16.43%
-59.3M
N/A
Total Nonoperating Income and Expense
103.5M
+80.43%
57.4M
N/A
Income before Taxes
-1.2B
+206.40%
-405.7M
N/A
Income Taxes
6.9M
-33.43%
10.4M
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
Net Income
-1.2B
+206.40%
-405.7M
N/A
Net Income from Continuing Operations Applicable to Common
-1.2B
+206.40%
-405.7M
N/A
Basic EPS and Net Income
-3.49
+160.45%
-1.34
N/A
Diluted EPS and Net Income
-3.49
+160.45%
-1.34
N/A
Basic Weighted Average Shares
356.1M
+17.90%
302.1M
N/A
Diluted Weighted Average Shares
356.1M
+17.90%
302.1M
N/A
Balance Sheet
Cash and Cash Equivalents
1.2B
+33.89%
893.1M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.2B
+33.89%
893.1M
N/A
Total Current Assets
2.9B
+99.72%
1.5B
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
781.2M
-8.03%
849.5M
N/A
Total Long-Term Assets
1.0B
-10.86%
1.1B
N/A
Total Assets
N/A
N/A
N/A
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
Total Short-Term Debt
1.0B
+258.62%
290.0M
N/A
Total Current Liabilities
1.6B
+40.87%
1.2B
N/A
Total Long-Term Debt
1.3B
+54.35%
813.6M
N/A
Total Long-Term Liabilities
986.0M
-16.23%
1.2B
N/A
Total Liabilities
2.6B
+12.19%
2.3B
N/A
Retained Earnings
-844.0M
-8.13%
-918.7M
N/A
Total Stockholders Equity
1.3B
+386.65%
274.2M
N/A
Total Shares Outstanding
373.3M
+18.43%
315.2M
N/A
Cash Flow
Cash from Operating Activities
-1.2B
+954.38%
-111.4M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
Cash from Investing Activities
-1.0B
+176.23%
-362.0M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
Cash from Financing Activities
2.5B
+706.98%
314.8M
N/A
Financials Ratio
Gross Margin
90.65%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
Return on Equity
-154.56%
N/A
N/A
N/A
Revenue Growth
-26.41%
N/A
N/A
N/A
Current Ratio
1.79
N/A
N/A
N/A
Cash Ratio
0.73
N/A
N/A
N/A
Debt-to-Equity Ratio
1.72
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow